Rosetta Genomics completes direct public offering and private placement

Rosetta raised $5 million in a registered direct offering

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE